# To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .

> **NCT00150358** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 253 (—)

## Conditions studied

- Impotence
- Hypertension

## Interventions

- **DRUG:** Sildenafil Citrate

## Key facts

- **NCT ID:** NCT00150358
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 253 (—)
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150358, "To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00150358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*